What the source record establishes
Smile Digital Health's OmniCompli CMS Suite+ combines FHIR-based CMS API infrastructure with computable policy, CQL, Da Vinci-aligned prior authorization, rule governance, and deterministic adjudication components.
The maintained taxonomy connects that documented market position to Authorization Requirement Discovery. This page keeps the claim at the level supported by the source: Smile Digital Health presents an offering relevant to this work. It does not silently convert a product description into an observed result, a conformity finding, or a universal recommendation.
Current fit signal: Payers evaluating a FHIR data platform with CMS compliance APIs plus computable policy and prior authorization automation.
What authorization requirement discovery means in this market
Authorization Requirement Discovery should be evaluated as an operating chain rather than a feature label. The chain begins with a named business condition and governed input, passes through configured logic and accountable review, produces an output or action, handles exceptions, and preserves enough evidence for another person to reconstruct the decision later.
Documentation completeness and burden
Risk that payer requirements are unclear or unavailable, relevant clinical evidence is missing or duplicated, and clinicians or staff must re-enter information across incompatible forms, portals, calls, or transactions.
Policy, benefit, and change management
Risk that authorization lists, benefit rules, medical policies, clinical criteria, coding, service-line scope, or delegated arrangements change without accurate versioning, implementation, provider notice, and downstream testing.
Who owns the decision
A capability can be technically available while operating ownership remains fragmented. The evaluation should name the person accountable for policy or business interpretation, the person responsible for configuration and data, the reviewer with authority to resolve exceptions, the approver of release or action, and the owner of monitoring and retirement.
Smile Digital Health should be asked to distinguish what the product decides, what it recommends, what it merely displays, and what remains an organizational judgment. A generic “human in the loop” statement is inadequate unless the human has time, context, evidence, and authority.
Evidence package to request from Smile Digital Health
- The exact product and package proposed, with a dated list of native, integrated, partner, service, and customer-owned components.
- A representative input set, its authoritative source, permitted use, quality checks, and version history.
- The configured workflow from intake through review, exception, approval, action, retention, and export.
- A normal result and at least two difficult exceptions, including one caused by missing or contradictory evidence.
- Role and access definitions for configuration, review, approval, override, monitoring, and administration.
- An implementation map naming integrations, migrations, customer work, provider work, services, test environments, and release gates.
- A retained decision record showing source, logic or model version, user action, timestamps, disposition, and downstream effect.
- A measurement plan with baseline, observation period, population, error threshold, exclusions, and stop condition.
Demonstration script
- Which exact Smile Digital Health product, edition, module, service, and geography support authorization requirement discovery?
- What source data, content, rules, and integrations does Smile Digital Health require before the workflow can begin?
- Where does human judgment enter, and which person can approve, reject, override, or stop the authorization requirement discovery workflow?
- How does the proposed configuration handle missing data, conflicting evidence, changed rules, and an expired or revoked approval?
- What record preserves inputs, transformations, user actions, exceptions, outputs, timestamps, and downstream consequences?
- Which parts are native, partner-delivered, service-delivered, or left to the customer?
- What can be exported at implementation, audit, renewal, migration, and exit?
- Which observation would falsify the current fit hypothesis for Smile Digital Health?
- Can the workflow discover the payer's current documentation requirements before submission?
- Which EHR data can be retrieved automatically and what must a user review or supply?
- How does the system identify missing, stale, contradictory, or irrelevant clinical information?
- Are payer questionnaires represented as maintainable computable logic or static forms?
Use the same scenario with every finalist. Let the provider explain differences in architecture, but keep the business condition, required evidence, exception, and expected decision record constant. That makes the evaluation comparable without pretending that unlike products should receive one synthetic score.
Failure modes and boundary conditions
- a polished normal path that hides missing or contradictory evidence
- an automation step that exceeds the user's authority
- a score or generated explanation that cannot be traced to a source and version
- an exception that disappears into email or an unexportable activity log
Transaction, auto-adjudication, burden-reduction, and covered-life figures are vendor-reported. Conformance, policy fidelity, clinical governance, and performance at customer scale require independent implementation evidence.
A buyer should also distinguish absence of public evidence from evidence of absence. If Smile Digital Health has not publicly documented a required detail, the correct status is “not established in this review” until a current, attributable source or direct observation resolves it.
Authority and standards context
CMS-0062-P
It could materially reduce the current boundary between medical-service and drug prior authorization regulation while changing standards, response times, and metrics. Buyers must plan for the possibility without treating proposed provisions as current obligations.
Interpretation boundary: Prior Auth Monitor does not provide patient-specific medical advice, determine coverage, authorize care, or establish final payment. Its records support organizational research and operating review.
This mapping identifies a workflow that may help organize evidence. It does not state that Smile Digital Health conforms to, complies with, or is certified against the authority.
HL7 Da Vinci CRD v2.2.1
Requirement discovery is a distinct workflow stage. A provider should know that authorization is required and what comes next before assembling or submitting a case; CRD addresses that stage rather than final determination.
Interpretation boundary: Prior Auth Monitor does not provide patient-specific medical advice, determine coverage, authorize care, or establish final payment. Its records support organizational research and operating review.
This mapping identifies a workflow that may help organize evidence. It does not state that Smile Digital Health conforms to, complies with, or is certified against the authority.
NCPDP SCRIPT v2023011
Pharmacy ePA follows a distinct NCPDP transaction path from medical-service prior authorization. Buyers must confirm supported SCRIPT versions, network participants, attachments, renewals, and transition readiness.
Interpretation boundary: Prior Auth Monitor does not provide patient-specific medical advice, determine coverage, authorize care, or establish final payment. Its records support organizational research and operating review.
This mapping identifies a workflow that may help organize evidence. It does not state that Smile Digital Health conforms to, complies with, or is certified against the authority.
Comparable records to inspect
The following organizations also have current official positioning mapped to authorization requirement discovery. Inclusion is a research pathway, not a shortlist or claim of equivalence.
- Onyx Health — FHIR Interoperability And Compliance Infrastructure with documented positioning relevant to Authorization Requirement Discovery
- Availity — Payer-Provider Authorization Network And Clearinghouse with documented positioning relevant to Authorization Requirement Discovery
- Carelon Medical Benefits Management — Delegated Specialty Utilization Management Organization with documented positioning relevant to Authorization Requirement Discovery
- CenterX — Pharmacy Electronic Prior Authorization And Medication-Access Network with documented positioning relevant to Authorization Requirement Discovery
- Cohere Health — Delegated Specialty Utilization Management Organization with documented positioning relevant to Authorization Requirement Discovery
- CoverMyMeds — Pharmacy Electronic Prior Authorization And Medication-Access Network with documented positioning relevant to Authorization Requirement Discovery
Official authority sources
The following primary authority pages support the standards context used in this record. They define an evaluation boundary; they do not endorse Smile Digital Health or establish product conformity.
CMS-0062-P
Open the official authority source and confirm the current text, effective date, scope, and organization-specific applicability before relying on this mapping.
HL7 Da Vinci CRD v2.2.1
Open the official authority source and confirm the current text, effective date, scope, and organization-specific applicability before relying on this mapping.
NCPDP SCRIPT v2023011
Open the official authority source and confirm the current text, effective date, scope, and organization-specific applicability before relying on this mapping.
Conditional conclusion
Smile Digital Health belongs in deeper evaluation for authorization requirement discovery when its documented FHIR interoperability and compliance infrastructure operating model matches the buyer's real workflow, the proposed package contains the required components, and a representative test produces reviewable evidence through normal and exception paths. The conclusion should be reversed or narrowed when the product boundary, source data, authority mapping, integration burden, human decision rights, exportability, or measured result does not meet the stated approval conditions.